Study: Genetic information can encourage women to accept preventive cancer treatment

CHICAGO ?-- Studies show that the risk of breast cancer can be reduced by half through the use of a five-year course of tamoxifen or raloxifene, and also by aromatase inhibitors. Nevertheless, women at high risk of breast cancer have a low acceptance of preventive medicine. A new study by Mayo Clinic and collaborators at [...]
Source: Mayo Clinic Minnesota News - Category: Hospital Management Source Type: news